Global Covid deaths estimated to reach 5.3 million by December

There have been almost 4.3 million deaths from Covid-19 globally since the start of the pandemic, according to the World Health Organization.

Funeral
A family members pays tribute to a Covid victim at a cremation ground in Guwahati (Photo: PTI)
Shawna Kwan | Bloomberg
1 min read Last Updated : Aug 07 2021 | 9:39 AM IST
The world will see 5.3 million reported deaths and 12 million excess fatalities by December as the delta variant drives a surge in Covid-19 cases, according to projections by the Institute for Health Metrics and Evaluation.\
 
The U.S.-based institute expects deaths to peak at the beginning of September then slowly decline afterward, it said in a report published Friday. The IHME’s forecasts distinguish between officially reported Covid-19 deaths and excess deaths attributed to the illness including unreported fatalities.

There have been almost 4.3 million deaths from Covid-19 globally since the start of the pandemic, according to the World Health Organization.

The delta variant is associated with viral loads that are more than 1,200 times higher in newly infected individuals compared with the original coronavirus strain, which means that delta can spread as easily as chickenpox. Studies from the U.K. have also shown that delta, which was discovered in India in October, is more resistant to vaccines than the alpha variant that emerged in England in late 2020.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story